I am a medical epidemiologist (MD in 1988 at Paris V, specialisation in rheumatology in 1990, Paris V, and DrPH from Harvard School of Public Health in 1993) specialized in infectious diseases epidemiology. After working at WHO at the clinical research unit of the Global Program on AIDS (1993-1994), I spent five years in Ethiopia and two years in the Netherlands working as the Program Manager of the Ethio-Netherlands AIDS Research Project (1994-2001). In 2002, I joined Institut Pasteur to launch the Emerging Diseases Epidemiology unit. There, my focus has been on viral hepatitis C (North-Coordinator of the ANRS research site on viral hepatitis; www.hepnile.org) and emerging infections such as the SARS (Scientific Coordinator of the EPISARS project which aimed prevent the re-emergence of SARS through the control of its animal reservoir) and the MERS-CoV. I also have a strong teaching involvement, as co-Director and founder of the Pasteur-Cnam School of Public Health (http://ecole-pasteur.cnam.fr), and coordinator of a master in public health with strong focus on infectious diseases. In 2014, I was appointed as Director of the newly created Pasteur Centre for Global Health Research and Education.
INCEPTION – Institut Convergence for the study of Emergence of Pathology Through Individuals and Populations
IINCEPTION Goal The Inception’s goal is to develop a core structure to mobilize data resources, numerical sciences, and fundamental experimental biology in a range of health issues (Official website here : https://www.inception-program.fr/en). Inception program […]
The Healthy Human Global Project
Susceptibility to infections, disease progression and severity, and response to medical therapies and vaccines are highly variable from one individual to another. The complexity of individual immune responses is such that it has not […]
LabEx IBEID – Integrative Biology of Emerging Infectious Diseases
Presentation The aim of the Integrative Biology of Emerging Infectious Diseases (IBEID) project, coordinated by Professors Philippe Sansonetti and Pascale Cossart, is to develop a structure to anticipate and tackle emerging infectious diseases (EIDs). […]
AFRIPOX – A One Health approach of monkeypox in Centrafrican Republic
AFRIPOX : une approche One Health de la variole du singe en République Centrafricaine : Infection humaine, reservoir animal, écologie de la maladie et outils diagnostiques Le monkeypox est un Orthopoxvirus émergent responsable de […]
Emergency response to global threats of emerging and re-emerging pathogens
With over 125 years’ experience with infectious diseases, the Institut Pasteur and the Institut Pasteur International Network (IPIN), which is composed of 33 research institutes in 26 countries and five continents, are ideally positioned […]
Protected: Pasteur Human Genome
There is no excerpt because this is a protected post.
ANRS 12332 HepNile: Evaluation of “Real Life” Efficacy and Safety of antiviral treatments including new Direct Antiviral Agents among patients treated for Chronic Hepatitis C at Egyptian National Treatment Centres
Background: Clinical trials are performed under optimal conditions where patients are highly selected without co-morbidities, clinical supervision is provided by specialists, and strict protocols are used to enhance patient compliance. Due to this, results […]
HCV research in Egypt
Funding: ANRS & EC. The main research objectives of this multidisciplinary network funded by the ANRS and the EC are the assessment of the burden of HCV infection and disease in Egypt, the study […]
Epidemiology of Buruli ulcer in Cameroon
Funding: ANR, Fondation Raoul Follereau, Fondation SANOFI Espoir. In this new research program, we will conduct for the first time the simultaneous collection of environmental (plants and insects) and human samples in two […]
Acute Bacterial Meningitis Project: Investigation of the spatio-temporal dynamics of meningitis epidemics in Niger and the associated ecologic risk factors
Funding : DCI Monaco. In collaboration with epidemiologists from the Centre de Recherche Médicale et Sanitaire (CERMES) in Niamey, we are using recent advances in Geographic Information Systems and statistical methodology to investigate […]
2021Sex differences in the evolution of neutralizing antibodies to SARS-CoV-2., J Infect Dis 2021 Mar; (): .
2021In utero Zika virus exposure and neurodevelopment at 24 months in toddlers normocephalic at birth: a cohort study., BMC Med 2021 Jan; 19(1): 12.
2021Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France., Euro Surveill 2021 01; 26(1): .
2020Implementation of a Self-Triage Web Application for Suspected COVID-19 and Its Impact on Emergency Call Centers: Observational Study., J Med Internet Res 2020 11; 22(11): e22924.
2020Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic., Biologicals 2020 Nov; (): .
2020Fatal Outcome in a Hepatitis E Virus/Human Immunodeficiency Virus Co-Infected Malnourished Child in the Central African Republic., Infect Dis Rep 2020 Nov; 12(3): 82-86.
2020Age-specific mortality and immunity patterns of SARS-CoV-2., Nature 2020 Nov; (): .
2020Placental infection by Zika virus in French Guiana., Ultrasound Obstet Gynecol 2020 Nov; 56(5): 740-748.
2020Lockdown impact on COVID-19 epidemics in regions across metropolitan France., Lancet 2020 Sep; (): .
2020COVID-19 herd immunity: where are we?, Nat. Rev. Immunol. 2020 Sep; (): .
+View full list of publications